PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 96 filers reported holding PREVAIL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $28,412,000 | +39.2% | 1,231,552 | -38.6% | 0.00% | 0.0% |
| Q3 2020 | $20,415,000 | -5.3% | 2,005,360 | +38.7% | 0.00% | 0.0% |
| Q2 2020 | $21,551,000 | +55.9% | 1,446,343 | +27.5% | 0.00% | 0.0% |
| Q1 2020 | $13,823,000 | +22.7% | 1,133,979 | +59.3% | 0.00% | – |
| Q4 2019 | $11,269,000 | +106.4% | 711,774 | +60.0% | 0.00% | – |
| Q3 2019 | $5,461,000 | +313.7% | 444,734 | +344.7% | 0.00% | – |
| Q2 2019 | $1,320,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|